disA Antibody

What is DisA protein and why are antibodies against it important for research?

DisA (DNA integrity scanning protein A) functions as a checkpoint protein that responds to DNA damage and monitors genomic integrity, particularly at the onset of sporulation in bacteria such as Bacillus subtilis. It possesses diadenylate cyclase (DAC) activity responsible for synthesizing cyclic di-AMP (c-di-AMP) via condensation of two ATP molecules . DisA antibodies are critical research tools that enable the study of:

• DisA protein localization during bacterial stress responses

• Protein-protein interactions, particularly with regulatory partners like RadA

• Quantification of DisA expression levels under different experimental conditions

• Investigation of DisA's role in bacterial physiology and pathogenesis

The significance of these antibodies is heightened by evidence suggesting that c-di-AMP signaling influences bacterial growth regulation, as demonstrated in Mycobacterium species where RadA targets DisA to inhibit its cyclic di-AMP synthesis activity .

What are the optimal fixation and permeabilization methods for immunostaining with DisA antibodies?

For effective immunostaining with DisA antibodies, researchers should consider the following methodological approach:

• Fixation options:

  • 4% paraformaldehyde (15 minutes at room temperature) preserves protein structure while maintaining antigenicity

  • Light fixation with 2% formaldehyde can preserve DisA complex integrity

  • Avoid methanol fixation as it may disrupt the octameric DisA complex structure

• Permeabilization strategies:

  • For Gram-positive bacteria: lysozyme treatment (2 mg/mL, 10 minutes) followed by 0.1% Triton X-100

  • For mycobacterial species: combined treatment with lysozyme and lipase may be necessary due to their complex cell wall

  • Gentle permeabilization is crucial as excessive treatment may disrupt the DNA-binding activity of the C-terminal HhH domain of DisA

• Buffer considerations:

  • Use phosphate buffers rather than Tris-based buffers when studying active DisA as Tris may interfere with enzymatic activity

  • Include 5mM MgCl₂ when maintaining enzymatic function is important

Each bacterial species may require optimization, particularly when working with pathogenic species like M. tuberculosis that has been shown to encode a DAC that converts ATP or ADP to c-di-AMP .

How can I validate the specificity of a DisA antibody?

Validating DisA antibody specificity requires a multi-faceted approach:

• Genetic controls:

  • Test antibody against wild-type and DisA knockout strains

  • Use complemented knockout strains to confirm signal restoration

  • If possible, test against strains expressing tagged DisA variants as positive controls

• Biochemical validation:

  • Western blot analysis should show a single band at the expected molecular weight (~40-45 kDa depending on species)

  • Competitive binding assays with purified DisA protein to demonstrate specific displacement

  • Pre-absorption controls with recombinant DisA should eliminate specific signal

• Cross-reactivity assessment:

  • Test against related bacterial species with varying levels of DisA homology

  • Check for reactivity against related diadenylate cyclase domain-containing proteins

  • Evaluate performance in species where DisA orthologs exist, such as M. tuberculosis and M. smegmatis

Thoroughness in validation is particularly important given that DisA can form octameric complexes and its conformation may be affected by DNA binding through its C-terminal HhH domain .

How can DisA antibodies be used to study the regulation of c-di-AMP synthesis under different conditions?

DisA antibodies enable sophisticated investigation of c-di-AMP regulation through several methodological approaches:

• Chromatin immunoprecipitation (ChIP) analysis:

  • Use DisA antibodies to pull down protein-DNA complexes

  • Sequence associated DNA to identify genomic regions where DisA binds

  • Compare binding patterns before and after DNA damage induction

  • This approach can reveal how branched DNA structures affect DisA localization, which is significant as branched DNA can strongly suppress the DAC activity of DisA

• Co-immunoprecipitation for regulatory partner identification:

  • Use DisA antibodies to precipitate protein complexes

  • Mass spectrometry analysis of co-precipitated proteins can identify new interaction partners

  • Confirm interactions with known regulators like RadA, which has been shown to physically interact with DisA to inhibit its c-di-AMP synthesis activity in M. smegmatis

• Quantitative immunoblotting for expression regulation:

  • Track DisA protein levels across growth phases, stress conditions, and genetic backgrounds

  • Combine with RT-qPCR to distinguish between transcriptional and post-transcriptional regulation

  • Compare with direct measurements of c-di-AMP levels to correlate protein abundance with activity

• Immunofluorescence microscopy for subcellular localization:

  • Track DisA redistribution during DNA damage response

  • Use co-localization with DNA damage markers to quantify recruitment kinetics

These approaches provide a comprehensive view of how DisA activity is regulated at multiple levels, from expression to localization to protein-protein interactions.

What methodological approaches enable the study of DisA-RadA interaction using antibodies?

The interaction between DisA and RadA represents a critical regulatory mechanism for c-di-AMP synthesis. To investigate this interaction:

• Proximity ligation assay (PLA):

  • Use separate DisA and RadA antibodies raised in different species

  • PLA signal indicates proximity (<40 nm) between proteins

  • Quantify interaction dynamics under different conditions

  • This technique can provide spatial and temporal resolution of the DisA-RadA interaction described in M. smegmatis

• Förster resonance energy transfer (FRET) with labeled antibodies:

  • Label anti-DisA and anti-RadA antibodies with compatible fluorophores

  • Measure FRET efficiency as indicator of interaction

  • Live-cell compatible for temporal studies

• Sequential immunoprecipitation (IP) strategy:

  • First IP with anti-DisA antibody

  • Elute and perform second IP with anti-RadA antibody

  • Analysis of doubly-precipitated material ensures only complexes containing both proteins are analyzed

  • This approach can help confirm the physical interaction between RadA and DisA that leads to inhibition of c-di-AMP synthesis activity

• Domain-specific antibodies for interaction mapping:

  • Generate antibodies against specific DisA domains (N-terminal DAC domain, C-terminal HhH domain)

  • Use competitive binding assays to determine which domains are involved in RadA interaction

  • This can provide insight into how RadA inhibits DisA activity - whether by blocking the DAC domain directly or by interfering with DNA binding by the HhH domain

How can epitope selection impact DisA antibody functionality in research applications?

Epitope selection critically influences DisA antibody performance and suitability for different applications:

• DAC domain-targeting antibodies:

  • Most useful for studying enzymatic activity regulation

  • May interfere with c-di-AMP synthesis in functional assays

  • Can potentially block RadA interaction if binding sites overlap

  • Crucial consideration: The N-terminal diadenylate cyclase domain of DisA is responsible for converting ATP to c-di-AMP through condensation

• HhH domain-targeting antibodies:

  • Ideal for studying DNA binding functions

  • May interfere with DNA scanning activity

  • Less likely to affect DAC enzymatic activity

  • Important consideration: The C-terminal HhH domain is responsible for the DNA-binding activity of DisA, particularly to branched DNA which can suppress DAC activity

• Linker region-targeting antibodies:

  • Less likely to interfere with either enzymatic or DNA-binding functions

  • May affect octamer formation if the epitope is involved in oligomerization

  • Often ideal for detection and localization studies

• Considerations for conformational epitopes:

  • DisA forms octameric complexes which may present unique conformational epitopes

  • Antibodies recognizing assembled complexes may not recognize denatured DisA in Western blots

  • May provide unique tools to distinguish between monomeric and oligomeric DisA

Researchers should select antibodies based on their specific experimental goals, with particular attention to whether functional inhibition is desired or should be avoided.

What are the optimal methods for using DisA antibodies in combination with functional c-di-AMP assays?

Integrating antibody-based detection with functional c-di-AMP measurements requires careful methodological planning:

• Sequential analysis approach:

  • First perform immunoprecipitation or immunodepletion of DisA

  • Follow with DAC activity assay on remaining sample or precipitated material

  • Compare activity with control samples to quantify specific contribution of DisA to total c-di-AMP synthesis

  • This approach can help quantify how factors like RadA inhibit DisA's c-di-AMP synthesis activity

• Immunodepletion-reconstitution strategy:

  • Deplete cell lysates of DisA using antibodies

  • Reconstitute with purified DisA variants

  • Measure resulting c-di-AMP synthesis capacity

  • This allows separation of DisA-dependent and independent c-di-AMP production

• In situ activity correlation:

  • Use antibodies to quantify DisA levels by immunoblotting or immunofluorescence

  • In parallel samples, measure c-di-AMP levels using mass spectrometry

  • Correlate DisA levels with c-di-AMP production under various conditions

• Antibody inhibition analysis:

  • Test if specific anti-DisA antibodies inhibit DAC activity in vitro

  • Use inhibitory antibodies as tools to specifically block DisA function in complex samples

  • Compare with effects of known inhibitors like branched DNA structures

How can DisA antibodies be employed to study bacterial pathogenesis mechanisms?

DisA antibodies offer unique insights into bacterial pathogenesis through several methodological approaches:

• Infection model expression analysis:

  • Use DisA antibodies to track protein expression during different stages of infection

  • Compare expression in virulent vs. attenuated strains

  • Correlate with measurements of c-di-AMP levels and bacterial survival

  • This is particularly relevant for pathogens like M. tuberculosis which encodes a DAC that can convert ATP or ADP to c-di-AMP

• Host-pathogen interaction studies:

  • Immunofluorescence to track DisA localization during host cell interaction

  • Determine if host factors affect DisA expression or localization

  • Investigate correlation between DisA activity and bacterial survival in phagocytes

• Genetic manipulation validation:

  • Use DisA antibodies to confirm knockout or knockdown efficiency

  • Validate complementation with wild-type or mutant DisA

  • Essential control for studies linking DisA function to virulence

• In vivo expression timing:

  • Immunohistochemistry of infected tissues to track DisA expression

  • Correlate with disease progression and bacterial dissemination

  • Identify infection stages where DisA function is most critical

These approaches can help establish the relationship between DisA function, c-di-AMP signaling, and bacterial pathogenesis, which is supported by evidence that c-di-AMP could be involved in regulation of bacterial physiology and pathogenesis .

What cross-reactivity considerations should researchers address when using DisA antibodies across bacterial species?

When applying DisA antibodies across bacterial species, researchers must address several cross-reactivity considerations:

• Sequence homology analysis:

  • Align DisA sequences from target species to determine conservation level

  • Identify species-specific regions versus conserved domains

  • Predict potential cross-reactivity based on epitope conservation

  • Important for studying DisA orthologs that exist in diverse species including M. tuberculosis and M. smegmatis

• Validation hierarchy:

  • Primary validation in species against which antibody was raised

  • Secondary validation in closely related species

  • Rigorous additional controls for distantly related species

  • Include species-specific positive and negative controls

• Domain-specific considerations:

  • Antibodies against the more conserved DAC domain may show broader cross-reactivity

  • Antibodies against species-variable regions provide specificity but limited cross-reactivity

  • Consider that DAC domains with similar function may have divergent sequences

• Recommended validation protocol:

  • Immunoblotting against recombinant DisA from each species of interest

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

  • Testing against knockout controls in each species when available

  • Side-by-side comparison of staining patterns to identify potential differences in localization

How can researchers distinguish between active and inactive forms of DisA using antibodies?

Distinguishing active from inactive DisA presents significant methodological challenges that can be addressed through several advanced approaches:

• Phosphorylation-state specific antibodies:

  • Develop antibodies against known regulatory phosphorylation sites

  • Use phospho-specific and total DisA antibodies in parallel assays

  • This approach requires prior knowledge of regulatory post-translational modifications

• Conformation-sensitive antibodies:

  • Screen for antibodies that preferentially recognize ATP-bound (active) DisA

  • Develop antibodies that distinguish between DNA-bound and free DisA

  • DNA binding through the C-terminal HhH domain of DisA is significant as branched DNA can strongly suppress the DAC activity of DisA

• Proximity-based activity reporting:

  • Use DisA antibodies in proximity ligation assays with antibodies against known interaction partners

  • Different interaction profiles may correlate with active/inactive states

  • Include RadA detection, as RadA physically interacts with DisA to inhibit its c-di-AMP synthesis activity

• Combined immunoprecipitation and activity workflows:

  • Immunoprecipitate DisA from different cellular conditions

  • Measure DAC activity of the precipitated protein

  • Correlate immunoprecipitation efficiency with recovery of enzymatic activity

This multi-faceted approach allows researchers to build a comprehensive profile of DisA activation states under various experimental conditions.

What are the methodological considerations for detecting DisA in bacterial biofilms using antibodies?

Biofilm research presents unique challenges for DisA antibody applications:

• Sample preparation optimization:

  • Develop specialized fixation protocols that preserve biofilm architecture

  • Test penetration of antibodies through extracellular matrix

  • Consider sectioning approaches for thick biofilms

  • Optimize permeabilization to ensure antibody access without disrupting DisA localization

• Specialized imaging approaches:

  • Confocal microscopy with z-stack analysis to localize DisA through biofilm depth

  • Super-resolution techniques to distinguish DisA clusters

  • Correlative light-electron microscopy to relate DisA localization to biofilm ultrastructure

• Quantification strategies:

  • Develop automated image analysis workflows for DisA quantification in 3D biofilm space

  • Use reference markers to normalize DisA signal across biofilm regions

  • Consider flow cytometry of dispersed biofilms for higher-throughput quantification

• Controls and validations:

  • Include fluorescent protein-tagged DisA strains as controls for antibody penetration

  • Use multiple antibody clones targeting different DisA epitopes

  • Validate findings with complementary techniques (e.g., mass spectrometry of biofilm fractions)

These methodological considerations enable researchers to investigate the role of DisA and c-di-AMP signaling in biofilm formation and maintenance.

How can computational antibody design approaches be applied to develop improved DisA antibodies?

Computational approaches offer promising avenues for DisA antibody development:

• Structure-guided epitope selection:

  • Use DisA crystal structures or models to identify accessible, stable epitopes

  • Target conserved regions for broad cross-reactivity or variable regions for species specificity

  • Consider the octameric structure of DisA when selecting epitopes that will be accessible in the native protein

• Applying RosettaAntibodyDesign for DisA antibody optimization:

  • Start with existing antibody frameworks with proven stability

  • Optimize binding interface for DisA-specific epitopes

  • Consider that computational protein design is challenging, particularly for one-sided interface design

  • Important considerations from RosettaAntibodyDesign experience:

    • Design multiple antibody variants (at least 20 designs per project for redesign purposes)

    • Run computations on large clusters to generate sufficient decoys

    • Selective approach to CDR design rather than attempting to redesign all CDRs simultaneously

    • Use pareto-optimal relax on native structures before design to avoid drastic energy value shifts

• Validation requirements for computationally designed antibodies:

  • Initial screening by ELISA and SPR to confirm binding

  • Functional assays to verify antibody utility in research applications

  • Side-by-side comparison with conventional antibodies

  • Consider that experimental validation is essential as computational designs may have perfect energy scores but still fail to bind in experimental settings

• Iterative optimization strategy:

  • Begin with broad computational design

  • Test initial candidates experimentally

  • Use experimental data to refine computational parameters

  • Repeat design-test cycle to improve antibody performance

How might single-domain antibodies enhance DisA localization and functional studies?

Single-domain antibodies (nanobodies) offer several methodological advantages for DisA research:

• Intracellular expression capabilities:

  • Express functional anti-DisA nanobodies within live bacteria

  • Track DisA localization and dynamics in real-time

  • Create inducible inhibitory nanobodies to control DisA function

  • This approach enables studying dynamic processes like DNA damage scanning by DisA

• Improved access to structured protein complexes:

  • Smaller size allows access to epitopes obscured in the DisA octameric complex

  • Can potentially distinguish between monomeric and complexed DisA

  • May access interfaces between DisA and interaction partners like RadA

• Super-resolution microscopy applications:

  • Direct conjugation of fluorophores to nanobodies

  • Reduced linkage error improves localization precision

  • Compatible with techniques like DNA-PAINT for multiplexed imaging

• Structure-function research methods:

  • Co-crystallization of nanobody-DisA complexes for structural insights

  • Use of conformation-specific nanobodies to trap and study specific DisA states

  • Potential to distinguish active from inactive DisA conformations

These approaches could significantly advance understanding of DisA dynamics and regulation, particularly when studying its role as a checkpoint protein for DNA damage response.

What methodological approaches can address the challenges of studying DisA in slow-growing pathogenic bacteria?

Studying DisA in slow-growing pathogens like M. tuberculosis presents unique challenges requiring specialized approaches:

• Long-term expression monitoring:

  • Use stable epitope tags to track DisA expression over extended periods

  • Develop antibodies against species-specific DisA variants

  • Implement inducible reporters to correlate with antibody detection

  • Particularly important as M. tuberculosis DisA has been shown to encode a DAC that can convert ATP or ADP to c-di-AMP

• Low-abundance detection strategies:

  • Implement signal amplification techniques (tyramide signal amplification, etc.)

  • Develop high-affinity antibodies with optimized detection sensitivity

  • Use microfluidic-based single-cell analysis for heterogeneous populations

• Biosafety-compatible workflows:

  • Develop fixation protocols compatible with both antibody reactivity and biosafety requirements

  • Optimize extraction methods for pathogenic bacteria that preserve DisA structure

  • Create inactivation protocols that don't destroy epitope recognition

• Correlation with disease models:

  • Track DisA expression and localization across infection models

  • Correlate with bacterial persistence, dormancy, and reactivation

  • Integrate with transcriptomic and metabolomic data for systems-level understanding

These approaches enable study of DisA function in clinically relevant pathogenic species while addressing the technical challenges they present.

How can DisA antibodies contribute to understanding the relationship between bacterial stress response and pathogenesis?

DisA antibodies offer powerful tools for investigating links between stress response and pathogenesis:

• Stress condition immunoprofiling:

  • Track DisA expression and localization across diverse stress conditions

  • Correlate DisA dynamics with c-di-AMP levels and bacterial survival

  • Map conditions that alter DisA-RadA interactions that regulate c-di-AMP production

  • Identify stressors that trigger DisA-mediated responses

• Host-induced stress response analysis:

  • Monitor DisA during host cell interactions (phagocytosis, etc.)

  • Track changes during antimicrobial exposure

  • Correlate DisA activity with bacterial adaptation and survival

• Genetic interaction mapping:

  • Use DisA antibodies to validate genetic knockdowns/knockouts

  • Screen for genetic modifications that alter DisA expression or localization

  • Identify regulatory networks connecting DisA to other stress response systems

• Timeline of activation during infection:

  • Track temporal changes in DisA expression and activity during infection progression

  • Correlate with bacterial adaptation stages and host response

  • Identify critical windows where DisA function impacts pathogenesis outcomes

These approaches can elucidate how bacteria use DisA-mediated c-di-AMP signaling to adapt to host environments and establish persistent infections, particularly relevant given evidence that c-di-AMP could be involved in regulation of bacterial physiology and pathogenesis .